Carlsmed, Inc. (CARL)
NASDAQ: CARL · Real-Time Price · USD
13.73
0.00 (0.00%)
At close: Aug 12, 2026, 4:00 PM EDT
13.72
-0.01 (-0.07%)
After-hours: Aug 12, 2026, 4:15 PM EDT

Carlsmed Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Revenue
63.350.5127.1713.78
Revenue Growth
65.39%85.94%97.16%-
Gross Profit
48.538.0420.059.9
Operating Income
-38.67-30.57-24.12-18.59
Net Income
-36.35-30.22-24.85-18.9
Earnings Per Share
-1.43-2.12-6.11-4.86
EPS Growth
----

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Cash & Investments
89.32109.8940.237.37
Total Debt
21.9217.4117.1811.39
Net Cash (Debt)
67.4192.4823.05-4.02
Net Cash Growth
324.88%301.30%--
Net Cash Per Share
2.656.505.67-1.03

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
-34.15-28.98-25.47-17.48
Capital Expenditures
-0.43-0.64-0.18-0.14
Free Cash Flow
-34.58-29.62-25.65-17.62
Free Cash Flow Growth
----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Gross Margin
76.63%75.31%73.80%71.88%
Operating Margin
-61.09%-60.53%-88.80%-134.93%
Pretax Margin
-57.42%-58.67%-89.30%-137.16%
Profit Margin
-16.60%-58.67%-89.30%-137.16%
FCF Margin
-54.63%-58.64%-94.41%-127.85%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingAug '26 Dec '25 Dec '24 Dec '23
PS Ratio
5.846.50--